SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
2020 · Nature Medicine · 2,679 citations
https://doi.org/10.1038/s41591-020-0868-6
M
Masahiro Yoshida
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
203
Papers
8.8K
Citations
32
h-index
70
i10-index
Masahiro Yoshida is an academic researcher from Japan Steel Works (Japan). The author has contributed to research in topics: Intracranial Aneurysms: Treatment and Complications & Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & COVID-19 Clinical Research Studies. The author has an h-index of 32, co-authored 173 publications.
ORCID: 0000-0002-3521-5322Papers by this author
worksInvolvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis
2019 · Nature Communications · 539 citations
https://doi.org/10.1038/s41467-019-10991-7
Metformin attenuates lung fibrosis development via NOX4 suppression
2016 · Respiratory Research · 223 citations
https://doi.org/10.1186/s12931-016-0420-x
A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates
2022 · Cell · 193 citations
https://doi.org/10.1016/j.cell.2022.11.005
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
2024 · Nature · 109 citations
https://doi.org/10.1038/s41586-024-07575-x
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
2017 · Respiratory Research · 95 citations
https://doi.org/10.1186/s12931-017-0600-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat